University of Mississippi Medical Center CRS

Site Details

LOCATION

Division of Infectious Diseases

2500 State Street

Jackson, MS. 39216

601-984-5553

Get Directions

SiteType

CRS

CRS Coordinator

Jennifer Brumfield

jbrumfield@umc.edu

601-984-4891

CRS Leader

James Brock

jbbrock@umc.edu

601-984-5560

Site Trials

HIV comorbidities and complications

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.

COVID-19 and Mpox

Open and enrolling

A5418: A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Mpox Disease

A5418 (STOMP) is a study of tecovirimat (also known as TPOXX) for the treatment of human monkeypox virus (HMPXV) disease.